Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01709383 · ClinicalTrials.gov registry record · NA

Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia

A NA study of Aphasia, sponsored by Georgetown University.

Completed
Registry status
NA
Development phase
38
Enrollment target
2
Study locations

NCT01709383 is a NA study of Aphasia that has completed, run by Georgetown University. The registered enrollment target is 38 participants, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01709383, a NA study of Aphasia, has completed, sponsored by Georgetown University.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target
2
Study locations

Study Summary

This study tests whether weak electrical stimulation of the brain is effective in improving language or reading difficulties occurring after a brain injury or stroke.

Conditions Studied

Aphasia

Interventions

  • DEVICE Transcranial Direct Current Stimulation
  • DEVICE Sham Stimulation

Study Locations (2)

District of Columbia

  • MedStar National Rehabilitation Hospital - Washington D.C.
  • Georgetown University - Washington D.C.

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2012-12
Est. Completion 2015-09
Phase NA

Sponsor

Georgetown University

227 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01709383

The ClinicalTrials.gov registry entry for NCT01709383 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (54% lower). The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aphasia appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Direct Current Stimulation is the first listed.

NCT01709383 reports 2 study locations spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT01709383 about?

NCT01709383 is a clinical study titled "Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia". This study tests whether weak electrical stimulation of the brain is effective in improving language or reading difficulties occurring after a brain injury or stroke.

What is the current status of trial NCT01709383?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2012-12. Estimated completion is 2015-09.

What conditions does trial NCT01709383 study?

This clinical trial studies the following conditions: Aphasia.

What interventions are being tested in trial NCT01709383?

The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE), Sham Stimulation (DEVICE).

Who is sponsoring clinical trial NCT01709383?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01709383 being conducted?

This trial has 2 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Aphasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Aphasia

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.